By A Mystery Man Writer
There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Modern Radiation Therapy Techniques in the Treatment of Esophageal
Immunotherapy Improves Survival in Advanced Esophageal Cancer - NCI
New Gastric & Esophageal Cancer Treatment Breakthrough
Akeso's ivonescimab scores third breakthrough therapy designation
/ImageCropToolT4/imageTool/uploa
A Win for Adjuvant Immunotherapy in Esophageal Cancer
Advancements and challenges in oncolytic virus therapy for
New Targeted Treatments Emerge for Gastric and Esophageal Cancer
Tucatinib Approved for HER2-Positive Colorectal Cancer - NCI
New Breakthrough May Advance Triple Negative Breast Cancer
A crystal ball in the fight against esophageal cancer|Tokyo
Recent advances in immune therapies for gastric cancer
Mayo Clinic Q&A podcast: Esophageal cancer is one of the deadliest
The Future of Ovarian Cancer Treatment with Antibody-Drug
Comparative genomic analysis of esophageal squamous cell carcinoma